Search Results - "Emery, V. C."

Refine Results
  1. 1
  2. 2

    Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection by Danta, M., Semmo, N., Fabris, P., Brown, D., Pybus, O. G., Sabin, C. A., Bhagani, S., Emery, V. C., Dusheiko, G. M., Klenerman, P.

    Published in The Journal of infectious diseases (01-06-2008)
    “…Background. Human immunodeficiency virus (HIV) may influence the outcome and natural history of hepatitis C virus (HCV) infection through an impact on acute…”
    Get full text
    Journal Article
  3. 3

    Cytomegalovirus: recent progress in understanding pathogenesis and control by EMERY, V. C

    Published in QJM : An International Journal of Medicine (01-05-2012)
    “…Cytomegalovirus continues to be an important pathogen in a variety of patient groups especially the neonate and the transplant recipient, and has implicated in…”
    Get full text
    Journal Article
  4. 4

    Polyfunctional Cytomegalovirus‐Specific CD4+ and pp65 CD8+ T Cells Protect Against High‐Level Replication After Liver Transplantation by Nebbia, G., Mattes, F. M., Smith, C., Hainsworth, E., Kopycinski, J., Burroughs, A., Griffiths, P. D., Klenerman, P., Emery, V. C.

    Published in American journal of transplantation (01-12-2008)
    “…To determine whether polyfunctional CD4+ T‐cell responses coupled with CD8+ T‐cell responses against human cytomegalovirus (HCMV) are key to the control of…”
    Get full text
    Journal Article
  5. 5

    Human Herpesvirus Vaccines and Future Directions by Emery, V. C.

    Published in American journal of transplantation (01-02-2013)
    “…Over the last few years there has been an impressive increase in the virological and immunological tools available to detect both human herpesvirus (HHV) and…”
    Get full text
    Journal Article
  6. 6

    Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High‐Level Replication After Renal Transplantation by Mattes, F. M., Vargas, A., Kopycinski, J., Hainsworth, E. G., Sweny, P., Nebbia, G., Bazeos, A., Lowdell, M., Klenerman, P., Phillips, R. E., Griffiths, P. D., Emery, V. C.

    Published in American journal of transplantation (01-05-2008)
    “…Human cytomegalovirus (HCMV) remains an important cause of morbidity after allotransplantation, causing a range of direct effects including hepatitis,…”
    Get full text
    Journal Article
  7. 7

    Kinetics of Cytomegalovirus Load Decrease in Solid-Organ Transplant Recipients after Preemptive Therapy with Valganciclovir by Mattes, F. M., Hainsworth, E. G., Walker, A. F. Hassan, Burroughs, A. K., Sweny, P., Griffiths, P. D., Emery, V. C.

    Published in The Journal of infectious diseases (01-01-2005)
    “…The availability of valganciclovir (VGCV) has significantly simplified the treatment of human cytomegalovirus (HCMV) infection after solid-organ…”
    Get full text
    Journal Article
  8. 8

    Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss by Walter, S, Atkinson, C, Sharland, M, Rice, P, Raglan, E, Emery, V C, Griffiths, P D

    “…To investigate the relation between cytomegalovirus (CMV) viral load on dried blood spots (DBS) from newborn biochemical screening ("Guthrie") cards, and…”
    Get more information
    Journal Article
  9. 9

    Investigation of CMV disease in immunocompromised patients by Emery, V C

    Published in Journal of clinical pathology (01-02-2001)
    “…Cytomegalovirus (CMV) is a recognised cause of morbidity and mortality in immunocompromised individuals. This review will concentrate on recent advances in the…”
    Get full text
    Journal Article
  10. 10

    High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients by LJUNGMAN, P, WANG, F.-Z, CLARK, D. A, EMERY, V. C, REMBERGER, M, RINGDEN, O, LINDE, A

    Published in British journal of haematology (01-12-2000)
    “…The aim of this study was to correlate human herpesvirus (HHV)-6 viral load with clinical symptoms in allogeneic stem cell transplant (SCT) patients…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients by Buyck, H C, Prentice, H G F, Griffiths, P D, Emery, V C

    Published in Bone marrow transplantation (Basingstoke) (01-07-2010)
    “…The risks associated with in vivo and ex vivo use of Campath-1H and -1G in a cohort of 206 stem cell transplant recipients for human CMV (HCMV) DNAemia have…”
    Get full text
    Journal Article
  14. 14

    Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients : relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease by GOR, D, SABIN, C, PRENTICE, H. G, VYAS, N, MAN, S, GRIFFITHS, P. D, EMERY, V. C

    Published in Bone marrow transplantation (Basingstoke) (01-03-1998)
    “…Quantitative competitive PCR was used to monitor the quantity of cytomegalovirus (HCMV) in 1647 blood samples from 110 BMT recipients. DNAemia was detected in…”
    Get full text
    Journal Article
  15. 15

    Prediction of Cytomegalovirus Load and Resistance Patterns after Antiviral Chemotherapy by Emery, Vincent C., Griffiths, Paul D.

    “…Cytomegalovirus (CMV) replicates rapidly in its human host with a doubling time of ≈ 1 day. Using simple mathematical models we show that the efficacy of the…”
    Get full text
    Journal Article
  16. 16

    Encouraging prospects for immunisation against primary cytomegalovirus infection by Griffiths, P.D., McLean, A., Emery, V.C.

    Published in Vaccine (08-01-2001)
    “…Congenital cytomegalovirus (CMV) infection is the leading infectious cause of mental retardation in children. Using seroprevalence data from two large…”
    Get full text
    Journal Article
  17. 17

    Asymptomatic Primary Cytomegalovirus Infection: Virologic and Immunologic Features by Zanghellini, Felipe, Boppana, Suresh B., Emery, Vincent C., Griffiths, Paul D., Pass, Robert F.

    Published in The Journal of infectious diseases (01-09-1999)
    “…We followed 45 seronegative adolescents for acquisition of cytomegalovirus (CMV); 6 (5 female, 1 male) seroconverted after a median of 7.5 months. All were…”
    Get full text
    Journal Article
  18. 18

    Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation by Aldridge, R.W., Mattes, F.M., Rolando, N., Rolles, K., Smith, C., Shirling, G., Atkinson, C., Burroughs, A.K., Milne, R.S.B., Emery, V.C., Griffiths, P.D.

    Published in Transplant infectious disease (01-02-2015)
    “…Background Natural immunity against cytomegalovirus (CMV) can control virus replication after solid organ transplantation; however, it is not known which…”
    Get full text
    Journal Article
  19. 19

    The dynamics of human cytomegalovirus replication in vivo by Emery, V C, Cope, A V, Bowen, E F, Gor, D, Griffiths, P D

    Published in The Journal of experimental medicine (19-07-1999)
    “…Cytomegalovirus (CMV) is generally described as a slowly replicating virus. During studies of immunocompromised patients, we observed rapid changes in the…”
    Get full text
    Journal Article
  20. 20

    Viral infections and their impact on chronic renal allograft dysfunction by Söderberg-Nauclér, C, Emery, V C

    Published in Transplantation (15-06-2001)
    “…Viral infections, particularly those involving HCMV, are an important complication of renal transplantation. Transplantation protocols and treatment regimens…”
    Get full text
    Journal Article Conference Proceeding